InsidersTradesSigma
Browse the detailed record of transactions filed by Sigal Charles Elliott, Director. Director active across 1 companies, notably Vir Biotechnology, Inc.. In total, 3 filings have been logged. The latest transaction was filed on 23 May 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
3 of 3 declarations
Charles Elliott Sigal is a Board Member at Vir Biotechnology, Inc. As a board member, he participates in the governance and strategic decision-making of the company. His experience in the biopharmaceutical sector allows him to provide valuable insights for the company's development. Charles Sigal plays an active role in evaluating performance and growth opportunities.